Login

Healthcare

00:10:00
Next Target for Antibe Therapeutics' Proprietary Hydrogen Sulfide Platform: Inflammatory Bowel Disease (IBD)|Dan Legault, CEO, Antibe Therapeutics Inc.
00:10:00
Navigating Innovation and Customer Care in the Hearing Care Sector|Enrico Vita , CEO, Amplifon Spa .
00:10:00
New development partnership aims to revolutionize breast cancer diagnosis|Andrew Newland, CEO, Angle PLC.
00:10:00
Revolutionizing Neurodegenerative Disease Treatment| Dr. Maria Maccecchini, CEO, Annovis Bio Inc.
00:10:00
We are Advancing Immunology Solutions for a Better Future|Thomas K Equels, Chief Executive Officer,Hemispherx BioPharma
00:10:00
Develop disease modifying therapies to stop or reverse the progression of neurodegenerative diseases|ANTTI VUOLANTO,Chief Executive Officer,Herantis Pharma Oyj
00:10:00
we are focused on discovering developing and commercializing novel gene and cell therapies and vaccines|Jon Lieber, Chief Financial Officer,Histogenics Corp
00:10:00
Our naturally safe ingredients deliver pure nutritional performance and clinically-proven health benefits|Dr. Bomi Framroze,Chief Scientific Officer,Hofseth Biocare
00:10:00
Pharmaceutical solutions at every stage|Paul McDonald,Chief Executive Officer,
00:10:00
Venturing down unexplored paths|Carlos de sousa,CEO,Immunicum
00:10:00
Computing the future of medicine|Alan Whitmore,Chief Scientific Officer,E Therapeutics
00:10:00
Develop and launch solutions for challenges facing industries|Sean Smith,CEO,Eden Research
00:10:00
The science that protects life| Claus Egstrand,CEO,Enzymatica
00:10:00
Leading the development of sulforaphane based medicines|Dr Huw Jones, Executive Director,
00:10:00
Innovative vaccines for a healthier world|Bent U Frandsen, Chief Executive Officer,ExpreS2ion Biotech Holding
00:10:00
Improving sight in patients with severe vision loss|Brian M Strem,CEO,EyeGate Pharmaceuticals Inc

© 2017 - Townhall + Tv